Withdrawal of Track and Trace System for Drug Export Formulations.
The Director General of Foreign Trade has officially withdrawn Para 2.76 from the Handbook of Procedures 2023, which previously outlined the procedure for implementing the Track and Trace system for export consignments of drug formulations.
This change means that the responsibility for implementing the authentication system for drug formulations being exported will now fall under the Ministry of Health and Family Welfare. The implementation will follow the provisions set forth in the Drug Rules of 1945.
This update comes into effect immediately. For more details, exporters should refer to the Ministry of Health and Family Welfare for guidance on the new process.
DGFT
Legal
Company Secretarial
DGFT Notifications
Others
Recent Posts
- SCOMET Item Classification Consultant: Avoid Export Clearance Delays in 2026
- EEEs Covered in EPR E-Waste Registration: Which Products Require CPCB Registration in 2026?
- RoDTEP Scroll Status Pending on ICEGATE? Causes and Solutions (2026)
- Eligible Products Under ROSCTL Scheme: Complete 2026 Guide
- DGFT Eases One Star Export House Eligibility: What Exporters Need to Know
- DGFT Automates EO Extension for Advance Authorisation & EPCG: What Exporters Need to Know
- Latest ROSCTL Rates for Textile Products (2026 Updated List)
- ROSCTL Pending Status on ICEGATE? Here’s the Exact Solution
FeATURED ARTICLES
SARAL SIMS for Steel Imports in India – Complete Guide The Government of India has introduced SARAL SIMS (Simplified Steel…
Top Export Compliance Mistakes: DGFT Advance Authorization, EPCG & CPCB (2025 Guide) Exporting in India can feel like a legal…
Environmental Clearance CPCB: Quick Guide for Exporters If you’re an Indian exporter or manufacturer working under schemes like the Advanced…
DGFT e-BRC Rule 2025: Key Update for Advance Authorization & EPCG Holders The Directorate General of Foreign Trade (DGFT) has…

